-
China Domestic ECMO products approved for marketing
2023-01-05
On January 4, 2023, the Extracorporeal Membrane Oxygenation System Console and its matching disposable kit of Chinabridge (Shenzhen) Medical Technology Co., Ltd. are approved through emergency review by China NMPA, to ensure the treatment needs of patients with severe cases of COVID-19 infection according to the demands of epidemic prevention and control.
-
China updates COVID-19 diagnosis, treatment protocol
2023-01-10
Introducing a set of revisions, health authorities on Friday released the 10th edition of the country's COVID-19 treatment plan, which guides hospitals nationwide as Omicron-fueled outbreaks keep progression across the nation.
-
First domestic ECMO machine to play vital role
2023-01-10
The official launch of the first domestically developed extracorporeal membrane oxygenation machine will play an important role in helping treat COVID-19 patients in critical condition and boosting the development of the country's high-end medical devices.
-
China's latest COVID-19 control protocol highlights vaccination, personal protection
2023-01-10
China released its 10th edition of COVID-19 control protocol on Saturday, highlighting vaccination and personal protection.
-
COVID treatment Molnupiravir approved for import in China
2023-01-04
China's top drug regulator said on Friday that it has granted conditional market approval for the import of Merck's COVID-19 treatment, Molnupiravir.
-
Mr Xu Jinghe Attends the “CIMDR - GHWP Session & International Drug Regulatory Authorities Dialogue”
2022-12-28
On the evening of December 20, 2022, the "China International Medical Device Regulatory Forum (CIMDR) - Global Harmonization Working Party (GHWP) Session & International Drug Regulatory Authorities Dialogue" was held online. Mr Xu Jinghe, Deputy Commissioner of the National Medical Products Administration (NMPA), attended the meeting online and delivered keynote speech.
